Nanōmix

Nanomix Corporation is a medical device company based in San Leandro, California, founded in 2000. The company specializes in mobile point-of-care diagnostic systems that perform a variety of in vitro diagnostic tests in diverse environments. These systems aim to enhance healthcare delivery by providing diagnostic information at the initial point of patient interaction, including hospitals, nursing facilities, urgent care centers, airports, and schools. Nanomix focuses on portable diagnostic devices that enable rapid and accessible testing, improving patient outcomes by making diagnostic data readily available. The company is also developing additional diagnostic tests to expand its offerings. A notable project includes a collaboration with Tulane University to create a multiplex test for Ebola, Lassa fever, and dengue, which was deployed in Sierra Leone during the Ebola crisis. With a team of around 30 employees, Nanomix is committed to advancing mobile diagnostic solutions that support faster and more effective medical decision-making across various healthcare settings.

• Employees 30
• Founded 2000
• Annual Revenue $15000
• Total Funding $37570000